Clinical Trials Logo

Pancreatic Pseudocyst(s) clinical trials

View clinical trials related to Pancreatic Pseudocyst(s).

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02146352 Completed - Clinical trials for Pancreatic Pseudocyst(s)

AXIOS Stent With Electrocautery Enhanced Delivery System

Start date: June 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate the safety and effectiveness of the AXIOS Stent with Electrocautery Enhanced Delivery System for endoscopic transenteric drainage of pancreatic pseudocysts.

NCT ID: NCT01419769 Completed - Clinical trials for Pancreatic Pseudocyst(s)

AXIOS Stent & Delivery System Study

Start date: August 2011
Phase: N/A
Study type: Interventional

The Xlumena AXIOS Stent and Delivery System is an investigational device in the USA, and this study is being conducted under an Investigational Device Exemption (IDE) granted by the US Food and Drug Administration (FDA). The study design is prospective, multi-center, non-blinded, single-arm (nonrandomized) study. Up to 10 sites in the United States, European Community and/or Japan will enroll a total of 24 patients. A majority of the patients will be enrolled in the United States. Patients will be followed at (approximately) 30 days and/or 60 days depending upon pseudocyst resolution confirmation, at 1-week post-stent removal,and possibly at 3 and 6 month post-stent removal.